Live Breaking News & Updates on Hemophilia Center

Stay updated with breaking news from Hemophilia center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition. ....

United States , Margaret Ragni , Henry Fuchs , Hemophilia Center , Drug Administration , Pittsburgh Biomarin , San Rafael ,

FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition. ....

United States , Henry Fuchs , Margaret Ragni , Drug Administration , Hemophilia Center , Pittsburgh Biomarin , San Rafael ,

FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition. ....

United States , Henry Fuchs , Margaret Ragni , Hemophilia Center , Drug Administration , Pittsburgh Biomarin , San Rafael ,

FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition. ....

United States , Margaret Ragni , Henry Fuchs , Hemophilia Center , Drug Administration , Pittsburgh Biomarin , San Rafael ,

FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition. ....

United States , Margaret Ragni , Henry Fuchs , Hemophilia Center , Drug Administration , Pittsburgh Biomarin , San Rafael ,